贵州医科大学学报

2019, v.44;No.221(02) 243-248

[打印本页] [关闭]
本期目录(Current Issue) | 过刊浏览(Past Issue) | 高级检索(Advanced Search)

布地奈德及福莫特罗联合孟鲁司特钠对咳嗽变异性哮喘患者血清IL-6和TNF-α水平及肺功能的影响
Effects of Budesonide and Formoterol Combined with Montelukast Sodium on Serum IL-6 and TNF-α Expression and Lung Function in Patients with Cough Variant Asthma

王惠欣;
WANG Huixin;Department of Pneumology,Fangshan District Hospital of Traditional Chinese Medicine,Beijing;

摘要(Abstract):

目的:观察吸入布地奈德及福莫特罗联合口服孟鲁司特钠对咳嗽变异性哮喘(CVA)患者血清IL-6、TNF-α表达水平及肺功能的影响。方法:196例CVA患者分为对照组及治疗组,两组均采取CVA常规治疗,对照组吸入布地奈德及福莫特罗,治疗组在对照组基础上口服孟鲁司特钠,治疗10周;比较两组患者疗效、血清IL-6及TNF-α表达水平、1 s末用力呼气容积与用力肺活量比值(FEV1/FVC)、呼气峰流量变异率(PEFR)、Pa CO2、Pa O2及BODE指数,并对治疗组患者血清IL-6、TNF-α与FEV1/FVC、BODE指数进行相关性分析。结果:疗程结束时,治疗组疗效明显优于对照组(P <0. 05),FEV1/FVC、Pa O2显著高于对照组(P <0. 05),Pa CO2、PE-FR、BODE指数、血清IL-6和TNF-α水平显著低于对照组(P <0. 05);治疗组FEV1/FVC与IL-6(r=-0. 72,P=0. 01)和TNF-α(r=-0. 67,P=0. 02)呈负相关,BODE指数与IL-6 (r=0. 59,P=0. 03)和TNF-α(r=0. 74,P=0. 01)呈正相关。结论:布地奈德及福莫特罗联合孟鲁司特钠治疗CVA疗效确切,血清IL-6和TNF-α水平的变化与肺功能的损伤程度有关。
Objective: To observe the effects of Budesonide and formoterol combined with montelukast sodium on serum IL-6 and TNF-α expression and lung function in patients with cough variant asthma. Methods: 196 patients with CVA were divided into two groups: control group and treatment group,and both groups were treated with routine CVA. The control group inhaled budesonide and formoterol,and the treatment group took montelukast sodium on the basis of the control group for 10 weeks. The therapeutic efficacy,serum IL-6,TNF-α expression,1 s final forced expiratory volume and forced vital capacity ratio( FEV1/FVC),peak expiratory flow variability( PEFR),PaCO2,PaO2 and BODE index were compared between the two groups,and the correlation between serum of IL-6 as well as TNF-α and the index of FEV1/FVC as well as BODE was analyzed in treatment group.Results: At the end of the course of treatment,the curative effect of the treatment group was better than that of the control group( P < 0. 05),and FEV1/FVC and PaO2 was significantly higher than that in control group( P < 0. 05). The index of PaCO2,PEFR and BODE,serum IL-6 and TNF-α levels were significantly lower than those in control group( P < 0. 05). There was a negative correlation between FEV1/FVC as well as IL-6( r =-0. 72,P = 0. 01) and TNF-α( r = 0. 74,P = 0. 01) in the treatment group,and There was a positive correlation between BODE index and IL-6( r = 0. 59,P =0. 03) and TNF-α( r = 0. 74,P = 0. 01). Conclusion: Budesonide and formoterol combined with montelukast sodium is effective in the treatment of CVA,and the changes of serum IL-6 and TNF-αlevels are related to the degree of lung function injury.

关键词(KeyWords): 哮喘;肺功能;白细胞介素6;肿瘤坏死因子α;布地奈德;福莫特罗;孟鲁司特钠
asthma;lung function;interleukin 6;tumor necrosis factor α;budesonide;formoterol;montelukast sodium

Abstract:

Keywords:

基金项目(Foundation): 北京市科技计划课题“首都临床特色应用研究”(Z141107002514083)

作者(Author): 王惠欣;
WANG Huixin;Department of Pneumology,Fangshan District Hospital of Traditional Chinese Medicine,Beijing;

Email:

DOI: 10.19367/j.cnki.1000-2707.2019.02.025

参考文献(References):

文章评论(Comment):

序号(No.) 时间(Time) 反馈人(User) 邮箱(Email) 标题(Title) 内容(Content)
反馈人(User) 邮箱地址(Email)
反馈标题(Title)
反馈内容(Content)
扩展功能
本文信息
服务与反馈
本文关键词相关文章
本文作者相关文章
中国知网
分享